Infection with Burkholderia cepacia in cystic fibrosis: Outcome following lung transplantation

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 1, 2001, Pages 43-48

  Chaparro, C ^a   Maurer, J ^a   Gutierrez, C ^a   Krajden, M ^a   Chan, C ^a   Winton, T ^a   Keshavjee, S ^a   Scavuzzo, M ^a   Tullis, E ^a   Hutcheon, M ^a   Kesten, S ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AZATHIOPRINE; CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; PREDNISONE; TOBRAMYCIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; CYTOMEGALIC INCLUSION BODY DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL;

EID: 0035148737     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.1.9811076     Document Type: Article

References (43)

1. Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation
2. Heart and lung transplant for terminal cystic fibrosis
3. Heart lung transplantation for end stage respiratory disease in cystic fibrosis patients at Papworth Hospital
4. Tenth Official Report - 1993
5. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator
6. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis
7. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
8. Pseudomonas cepacia colonization among patients with cystic fibrosis: A new opportunist
9. Hypergammaglobulinemia in cystic fibrosis: Role of Pseudomonas endobronchial infection
10. Colonization on the respiratory tract with Pseudomonas cepacia in cystic fibrosis: Risks factors and outcomes
11. Pseudomonas cepacia colonization of cystic fibrosis patients: Risk factors and clinical outcome
12. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
13. Pseudomohas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis
14. Improved results of lung transplantation for patients with cystic fibrosis
15. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome
16. Bilateral lung transplantation for cystic fibrosis
17. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis
18. Preoperative assessment for lung transplantation
19. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis
20. Nonparametric elimination from incomplete observations
21. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts
22. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
23. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis
24. Recent advances in cystic fibrosis research
25. Infectious complications of lung transplantation: Impact of cystic fibrosis
26. Emerging therapies for cystic fibrosis
27. The changing epidemiology of cystic fibrosis
28. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers
29. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
30. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF center epidemics in North America and Britain
31. Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping
32. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis
33. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (pseudomonas) cepacia: Nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers
34. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage
35. Microbiology of airway disease in patients with cystic fibrosis
36. Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa and Pseudomonas cepacia
37. In vitro activities of combination of aztreonam, ciprofloxacin and ceftazidime against isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients
38. A controlled double blind study of the hematologic toxicity of chloramphenicol
39. State wide study of chloramphenicol therapy and fatal aplastic anemia
40. Burkholderia cepacia infections in cystic fibrosis
41. Is survival that important?
42. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis
43. Evidence of transmission of Pseudomonas cepacia by social contact in cystic fibrosis